Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS

Table of Contents

September 01, 2016; Volume 43,Issue 9

Editorials

  • You have access
    A New Era in the Treatment of Scleroderma-associated Interstitial Lung Disease?
    DAVID LAUNAY
    The Journal of Rheumatology September 1 2016, 43 (9) 1619-1621; DOI: https://doi.org/10.3899/jrheum.160887

Articles

  • You have access
    Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis
    Eirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, Inge C. Olsen, Inger-Jorid Berg, Jonny Hisdal, Till Uhlig, Glenn Haugeberg, Tore K. Kvien, Sella A. Provan and Anne Grete Semb
    The Journal of Rheumatology September 1 2016, 43 (9) 1622-1630; DOI: https://doi.org/10.3899/jrheum.160053
  • You have access
    ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis
    Maria Pilar Lisbona, Albert Solano, Jesús Ares, Miriam Almirall, Tarek Carlos Salman-Monte and Joan Maymó
    The Journal of Rheumatology September 1 2016, 43 (9) 1631-1636; DOI: https://doi.org/10.3899/jrheum.150849
  • You have access
    Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies
    Robin L. Thurmond, Andrew Greenspan, Waldemar Radziszewski, Xie L. Xu, Ye Miao, Bin Chen, TingTing Ge, Bei Zhou, Daniel G. Baker, Dace Pavlova, Christopher T. Ritchlin, Yoshiya Tanaka, Tsutomu Takeuchi and Josef S. Smolen
    The Journal of Rheumatology September 1 2016, 43 (9) 1637-1642; DOI: https://doi.org/10.3899/jrheum.160164
  • You have access
    Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort
    Nasir T. Wabe, Michael J. Sorich, Mihir D. Wechalekar, Leslie G. Cleland, Leah McWilliams, Anita T.Y. Lee, Llewellyn D. Spargo, Robert G. Metcalf, Cindy Hall, Susanna M. Proudman and Michael D. Wiese
    The Journal of Rheumatology September 1 2016, 43 (9) 1643-1649; DOI: https://doi.org/10.3899/jrheum.151392
  • You have access
    Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: Spectrum, Drug Resistance, Outcomes, and Risk Factors
    Dongying Chen, Jingyi Xie, Haihong Chen, Ying Yang, Zhongping Zhan, Liuqin Liang and Xiuyan Yang
    The Journal of Rheumatology September 1 2016, 43 (9) 1650-1656; DOI: https://doi.org/10.3899/jrheum.151523
  • You have access
    Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus
    Claudia Mora, Jorge Medina-Rosas, Ana Maria Santos, Diego A. Jaimes, Ana M. Arbeláez, Consuelo Romero, Annie Cortes and John Londono
    The Journal of Rheumatology September 1 2016, 43 (9) 1657-1664; DOI: https://doi.org/10.3899/jrheum.150486
  • You have access
    The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil
    Ami A. Shah, Elena Schiopu, Soumya Chatterjee, Mary Ellen Csuka, Tracy Frech, Avram Goldberg, Robert Spiera, Stanford L. Peng, Ryan J. McBride, Jody M. Cleveland and Virginia Steen
    The Journal of Rheumatology September 1 2016, 43 (9) 1665-1671; DOI: https://doi.org/10.3899/jrheum.151437
  • Open Access
    An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
    Dinesh Khanna, Carlo Albera, Aryeh Fischer, Nader Khalidi, Ganesh Raghu, Lorinda Chung, Dan Chen, Elena Schiopu, Margit Tagliaferri, James R. Seibold and Eduard Gorina
    The Journal of Rheumatology September 1 2016, 43 (9) 1672-1679; DOI: https://doi.org/10.3899/jrheum.151322
  • You have access
    The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
    Milla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, Maxime Dougados, Florence Tubach, Nicholas Bellamy, Marc Hochberg, Philippe Ravaud, Emilio Martin-Mola, Hassane Awada, Claire Bombardier, David Felson, Najia Hajjaj-Hassouni, Isabelle Logeart, Marco Matucci-Cerinic, Mart van de Laar and Désirée van der Heijde
    The Journal of Rheumatology September 1 2016, 43 (9) 1680-1686; DOI: https://doi.org/10.3899/jrheum.151244
  • You have access
    Development of a Screening Tool for the Identification of Sacroiliitis in Computed Tomography Scans of the Abdomen
    Jonathan Chan, Ismail Sari, David Salonen, Robert D. Inman and Nigil Haroon
    The Journal of Rheumatology September 1 2016, 43 (9) 1687-1694; DOI: https://doi.org/10.3899/jrheum.150939
  • You have access
    Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis
    Eri Hayashi, Asako Chiba, Kurisu Tada, Keiichi Haga, Mie Kitagaichi, Shihoko Nakajima, Makio Kusaoi, Fumio Sekiya, Michihiro Ogasawara, Ken Yamaji, Naoto Tamura, Yoshinari Takasaki and Sachiko Miyake
    The Journal of Rheumatology September 1 2016, 43 (9) 1695-1703; DOI: https://doi.org/10.3899/jrheum.151133
  • You have access
    Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab
    Jürgen Braun, Xenofon Baraliakos, Kay-Geert A. Hermann, Stephen Xu and Benjamin Hsu
    The Journal of Rheumatology September 1 2016, 43 (9) 1704-1712; DOI: https://doi.org/10.3899/jrheum.160003
  • Open Access
    Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
    Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, Stephen Hall, Hector Chinoy, Alan J. Kivitz, Zailong Wang and Shephard Mpofu
    The Journal of Rheumatology September 1 2016, 43 (9) 1713-1717; DOI: https://doi.org/10.3899/jrheum.160275
  • You have access
    Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis
    Barry J. Sheane, Arane Thavaneswaran, Dafna D. Gladman and Vinod Chandran
    The Journal of Rheumatology September 1 2016, 43 (9) 1718-1723; DOI: https://doi.org/10.3899/jrheum.160111
  • You have access
    A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
    Maurizio Cutolo, Gary E. Myerson, Roy M. Fleischmann, Frédéric Lioté, Federico Díaz-González, Filip Van den Bosch, Helena Marzo-Ortega, Eugen Feist, Kamal Shah, ChiaChi Hu, Randall M. Stevens and Airi Poder
    The Journal of Rheumatology September 1 2016, 43 (9) 1724-1734; DOI: https://doi.org/10.3899/jrheum.151376
  • You have access
    Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis
    Hua Cao, Qunli Xia, Meng Pan, Xiaoqing Zhao, Xia Li, Ruofei Shi, Min Zhou, Xiaoyi Ding, Masataka Kuwana and Jie Zheng
    The Journal of Rheumatology September 1 2016, 43 (9) 1735-1742; DOI: https://doi.org/10.3899/jrheum.160024
  • You have access
    Widespread Pain and Low Widespread Pain Index Scores among Fibromyalgia-positive Cases Assessed with the 2010/2011 Fibromyalgia Criteria
    Frederick Wolfe, Niklaus Egloff and Winfried Häuser
    The Journal of Rheumatology September 1 2016, 43 (9) 1743-1748; DOI: https://doi.org/10.3899/jrheum.160153
  • You have access
    The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional Study
    Shay Brikman, Victoria Furer, Jonathan Wollman, Sara Borok, Hagit Matz, Arik Polachek, Ofir Elalouf, Amir Sharabi, Ilana Kaufman, Daphna Paran and Ori Elkayam
    The Journal of Rheumatology September 1 2016, 43 (9) 1749-1754; DOI: https://doi.org/10.3899/jrheum.151491

Pediatric Rheumatology

  • You have access
    The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010–2013
    Ginger Janow, Laura E. Schanberg, Soko Setoguchi, Victor Hasselblad, Elizabeth D. Mellins, Rayfel Schneider, Yukiko Kimura and CARRA Legacy Registry Investigators
    The Journal of Rheumatology September 1 2016, 43 (9) 1755-1762; DOI: https://doi.org/10.3899/jrheum.150997

Images in Rheumatology

  • You have access
    Unilateral Macular Lymphocytic Arteritis
    ANA ARANA-GUAJARDO, CYNTHIA MENDOZA-RODRÍGUEZ and IVETTE MIRANDA-MALDONADO
    The Journal of Rheumatology September 1 2016, 43 (9) 1763-1764; DOI: https://doi.org/10.3899/jrheum.160240

Correspondence

  • You have access
    Defining Low Disease Activity States in Psoriatic Arthritis Using Novel Composite Disease Instruments
    ENNIO LUBRANO and FABIO MASSIMO PERROTTA
    The Journal of Rheumatology September 1 2016, 43 (9) 1765-1766; DOI: https://doi.org/10.3899/jrheum.160386
  • You have access
    L.C. Coates and P.S. Helliwell reply
    LAURA C. COATES and PHILIP S. HELLIWELL
    The Journal of Rheumatology September 1 2016, 43 (9) 1766; DOI: https://doi.org/10.3899/jrheum.160727
  • You have access
    Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence
    CLAUDE BACHMEYER, SIMON GALMICHE, ANTOINE FAYAND, ALEXANDRE DEGACHI and SOPHIE GEORGIN-LAVIALLE
    The Journal of Rheumatology September 1 2016, 43 (9) 1766; DOI: https://doi.org/10.3899/jrheum.160437
  • You have access
    Dr. Tselios, et al reply
    KONSTANTINOS TSELIOS, DAFNA D. GLADMAN, JIANDONG SU and MURRAY B. UROWITZ
    The Journal of Rheumatology September 1 2016, 43 (9) 1767; DOI: https://doi.org/10.3899/jrheum.160749

Letters

  • You have access
    Four Cases of Anti-PM/Scl Antibody-positive Juvenile Overlap Syndrome with Features of Myositis and Systemic Sclerosis
    LAMPROS FOTIS, KEVIN W. BASZIS, ANDREW J. WHITE and ANTHONY R. FRENCH
    The Journal of Rheumatology September 1 2016, 43 (9) 1768-1769; DOI: https://doi.org/10.3899/jrheum.151445
  • You have access
    Development of Nephrotic Syndrome in a Patient with Rheumatoid Arthritis Treated with Certolizumab
    RONALD R. BUTENDIECK JR., TANYA BHATTACHARYA and XOCHIQUETZAL GEIGER
    The Journal of Rheumatology September 1 2016, 43 (9) 1770-1772; DOI: https://doi.org/10.3899/jrheum.160147

Corrections

  • You have access
    Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study
    The Journal of Rheumatology September 1 2016, 43 (9) 1772; DOI: https://doi.org/10.3899/jrheum.160363.C1
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 43, Issue 9
1 Sep 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)

Jump to

  • Editorials
  • Articles
  • Pediatric Rheumatology
  • Images in Rheumatology
  • Correspondence
  • Letters
  • Corrections
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • The Challenges of Developing Online Learning
  • Milwaukee Shoulder Syndrome: An Extreme Case
  • Relapsing Polychondritis and Large-vessel Vasculitis
  • The Effect of HLA-B27 on Susceptibility and Severity of COVID-19
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire